Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P61278 (
somatostatin
)
22,083
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
PTH2 receptor
is a G protein-coupled receptor selectively activated by PTH. We are studying the receptors distribution to guide the investigation of its physiological function. We have now generated an antibody from a C-terminal peptide sequence of the
PTH2 receptor
and used this to study its cellular distribution. Labeling with the antibody identified a number of endocrine cells expressing the
PTH2 receptor
, including thyroid parafollicular cells, pancreatic islet D cells, and some gastrointestinal peptide synthesizing cells. There was complete overlap of
PTH2 receptor
labeling with
somatostatin
in pancreatic islets, and partial overlap with
somatostatin
in thyroid parafollicular cells and in the gastrointestinal tract. Furthermore, observations made previously by in situ hybridization histochemistry, including expression throughout the cardiovascular system, as well as by discrete populations of cells within the gastrointestinal tract and reproductive system were confirmed. These data suggest a broad role for the
PTH2 receptor
, especially within the endocrine system, and provide a basis for experimental exploration of its physiology.
...
PMID:Distribution of the parathyroid hormone 2 receptor in rat: immunolocalization reveals expression by several endocrine cells. 1038 34
The human
PTH2 receptor
, expressed in tissue culture cells, is selectively activated by PTH. Detailed investigation of its anatomical and cellular distribution has been performed in the rat. It is expressed by neurons in a number of brain nuclei; by endocrine cells that include pancreatic islet
somatostatin
cells, thyroid parafollicular cells, and peptide secreting cells in the gastrointestinal tract; and by cells in the vasculature and heart. The physiological role of the
PTH2 receptor
expressed by these cells remains to be determined. All pharmacological studies performed to date have used the human receptor. We have now isolated a complementary DNA including the entire coding sequence of the rat
PTH2 receptor
and compared its pharmacological profile with that of the human
PTH2 receptor
when each is expressed in COS-7 cells. PTH-based peptides, including rat PTH(1-84), rat PTH(1-34), and human PTH(1-34), have low potency at the rat
PTH2 receptor
for stimulation of adenylyl cyclase (EC50 = 19-140 nM). When compared with the effect of a bovine hypothalamic extract, PTH-based peptides are partial agonists at the rat
PTH2 receptor
. This suggests that PTH is unlikely to be a physiologically important endogenous ligand for the
PTH2 receptor
. A peptide homologous to an activity detected in a bovine hypothalamic extract is a good candidate for the endogenous
PTH2 receptor
ligand.
...
PMID:Comparison of rat and human parathyroid hormone 2 (PTH2) receptor activation: PTH is a low potency partial agonist at the rat PTH2 receptor. 1049 94
The human
PTH2 receptor
binds and is activated at high potency by PTH and by the recently discovered peptide tuberoinfundibular peptide of 39 residues (TIP39). Rat and zebrafish PTH2 receptors are more weakly activated by PTH, suggesting that TIP39 may be the natural ligand for the
PTH2 receptor
. Unlike the PTH1 receptor, the
PTH2 receptor
interacts extremely weakly with parathyroid hormone-related peptide (PTHrP). The
PTH2 receptor
is strongly coupled to stimulation of cAMP accumulation, and more weakly, in a cell-specific manner to increases in intracellular calcium concentration. A variety of evidence supports the general model of receptor amino terminal sequences binding ligand carboxyl terminal sequences with high affinity, and ligand amino terminal sequences activating the receptor through interaction with the "juxtamembrane" portion of the receptor. The receptor is present at greatest levels in the nervous system. It is expressed in scattered cells in the cerebral cortex and basal ganglia and at relatively high abundance in the septum, midline thalamic nuclei, several hypothalamic nuclei, and the dorsal horn of the spinal cord. Peripherally, expression in pancreatic islet
somatostatin
cells is most dramatic. Functional hypotheses based on the receptor's distribution are being tested. Recent data support involvement in hypothalamic releasing-factor secretion and pain.
...
PMID:The parathyroid hormone 2 (PTH2) receptor. 1252 38
This study reports the distribution of
parathyroid hormone 2 receptor
(
PTH2R
)-immunoreactive fibers in the hypothalamus using fluorescent amplification immunocytochemistry. The pattern of immunolabeling is strikingly similar to that of tuberoinfundibular peptide of 39 residues (TIP39), a peptide recently purified from bovine hypothalamus and proposed to be a ligand of the
PTH2R
based on pharmacological data. To investigate the anatomical basis of suggestions that TIP39 affects the secretion of several hypophysiotropic hormones we performed double-labeling studies and found that only
somatostatin
fibers contain
PTH2R
in the median eminence, which suggests that
somatostatin
release could be directly regulated via the
PTH2R
. However, several hypothalamic nuclei projecting to the median eminence contain a high density of both TIP39 and
PTH2R
fibers and terminals. We report here, that the
PTH2R
terminals also contain vesicular glutamate transporter-2, and suggest that TIP39 terminals are ideally positioned to modulate glutamatergic influences on hypophysiotropic neurons.
...
PMID:The distribution and neurochemistry of the parathyroid hormone 2 receptor in the rat hypothalamus. 1657 Feb 12
Parathyroid hormone receptor 2 (
PTH2R
) and its ligand, tuberoinfundibular peptide of 39 residues (TIP39) constitute a neuromodulator system implicated in endocrine and nociceptive regulation. We now describe the presence and distribution of the
PTH2R
and TIP39 in the brain of primates using a range of tissues and ages from macaque and human brain. In situ hybridization histochemistry of TIP39 mRNA, studied in young macaque brain, due to its possible decline beyond late postnatal ages, was present only in the thalamic subparafascicular area and the pontine medial paralemniscal nucleus. In contrast, in situ hybridization histochemistry in macaque identified high levels of
PTH2R
expression in the central amygdaloid nucleus, medial preoptic area, hypothalamic paraventricular and periventricular nuclei, medial geniculate, and the pontine tegmentum.
PTH2R
mRNA was also detected in several human brain areas by RT-PCR. The distribution of
PTH2R
-immunoreactive fibers in human, determined by immunocytochemistry, was similar to that in rodents, including dense fiber networks in the medial preoptic area, hypothalamic paraventricular, periventricular and infundibular (arcuate) nuclei, lateral hypothalamic area, median eminence, thalamic paraventricular nucleus, periaqueductal gray, lateral parabrachial nucleus, nucleus of the solitary tract, sensory trigeminal nuclei, medullary dorsal reticular nucleus, and dorsal horn of the spinal cord. Co-localization suggested that
PTH2R
fibers are glutamatergic, and that TIP39 may directly influence hypophysiotropic
somatostatin
containing and indirectly influence corticotropin releasing-hormone containing neurons. The results demonstrate that TIP39 and the
PTH2R
are expressed in the brain of primates in locations that suggest involvement in regulation of fear, anxiety, reproductive behaviors, release of pituitary hormones, and nociception.
...
PMID:Parathyroid hormone 2 receptor and its endogenous ligand tuberoinfundibular peptide of 39 residues are concentrated in endocrine, viscerosensory and auditory brain regions in macaque and human. 1940 Dec 15